Mitchell G Lawrence

10PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 08, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.

Zifeng Wang, Scott L Townley, Songqi Zhang

|Apr 05, 2024
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer.

Nicholas Choo, Shivakumar Keerthikumar, Susanne Ramm

|Mar 07, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer research.

W Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna

|Mar 16, 2023
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.

Mohammadreza Alizadeh-Ghodsi, Katie L Owen, Scott L Townley

|Jan 17, 2023
The future of patient-derived xenografts in prostate cancer research.

Mitchell G Lawrence, Renea A Taylor, Georgia B Cuffe

|Aug 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.

Gail P Risbridger, Ashlee K Clark, Laura H Porter

Pageof 2